Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb

Annals of Thoracic Surgery

Volumn 81, Issue 3, 2006, Pages 935-942

  Jaillard, Sophie ^a   Larrue, Benoît ^a   Deruelle, Philippe ^a   Delelis, Anne ^a   Rakza, Thameur ^a   Butrous, Ghazwan ^a   Storme, Laurent ^a  

^a Polyclinique du Bois ^*

Author keywords

[No Author keywords available]

Indexed keywords

OXIDE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CATHETER; CAVA VEIN; CONTROLLED STUDY; DUCTUS ARTERIOSUS; FETUS; LAMB; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG VASCULAR RESISTANCE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY; SHEAR STRESS;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; DUCTUS ARTERIOSUS; FEMALE; FETUS; FORELIMB; FUNCTIONAL LATERALITY; HEMODYNAMIC PROCESSES; MODELS, ANIMAL; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; PREGNANCY; PULMONARY ARTERY; PULMONARY CIRCULATION; SHEEP; VASODILATION;

EID: 32644476489     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.09.022     Document Type: Article

References (34)

1. D.F. Teitel, H. Iwmoto, A.M. Rudolph Effects of birth related events on central blood flow patterns Pediatr Res 22 1987 557 566
2. D.L. Levin, M.A. Heyman, J.A. Kitterman, G.A. Gregory, R.H. Phibbs, A.M. Rudolph Persistent pulmonary hypertension of the newborn J Pediatr 89 1976 626 630
3. F.J. Walther, M.J. Benders, J.O. Leighton Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome Pediatrics 90 1992 899 904
4. A.B. Lewis, M.A. Heymann, A.M. Rudolph Gestational changes in pulmonary vascular responses in fetal lambs in utero Circ Res 39 1976 536 541
5. B.M. Tsai, M. Wang, M.W. Turrentine, Y. Mahomed, J.W. Brown, D.R. Meldrum Hypoxic pulmonary vasoconstriction in cardiothoracic surgery basic mechanisms to potential therapies Ann Thorac Surg 78 2004 360 368
6. D.D. Ivy, J.P. Kinsella, S.H. Abman Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation J Clin Invest 93 1994 2141 2148
7. D.N. Cornfield, B.A. Chatfield, J.A. McQueston, I.F. McMurtry, S.H. Abman Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus Am J Physiol 262 1992 H1474 H1481
8. J.P. Zenge, R.L. Rairigh, T.R. Grover NO and prostaglandin interactions during hemodynamic stress in the fetal ovine pulmonary circulation Am J Physiol Lung Cell Mol Physiol 281 2001 L1157 L1163
9. L. Storme, R.L. Rairigh, T.A. Parker, J.P. Kinsella, S.H. Abman In vivo evidence for a myogenic response in the fetal pulmonary circulation Pediatr Res 45 1999 425 431
10. M.S. Kabbani, S. Cassin The effects of cGMP on fetal sheep pulmonary blood flow and lung liquid production Pediatr Res 43 1998 325 330
11. K.F. Rabe, H. Tenor, G. Dent, C. Schudt, M. Nakashima, H. Magnussen Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors Am J Physiol 266 1994 L536 L543
12. K.A. Hanson, F. Burns, S.D. Rybalkin, J.W. Miller, J. Beavo, W.R. Clarke Developmental changes in lung cGMP phosphodiesterase-5 activity, protein, and message Am J Respir Crit Care Med 158 1998 279 288
13. R.C. Dukarm, J.A. Russell, F.C. Morin III, B.J. Perry, R.H. Steinhorn The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation Am J Respir Crit Care Med 160 1999 858 865
14. J.W. Ziegler, D.D. Ivy, J.J. Fox, J.P. Kinsella, W.R. Clarcke, S.H. Abman Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus Am J Respir Crit Care Med 157 1998 1104 1110
15. D.F. Anderson, J.M. Bissonette, J.J. Farber, K.L. Thornburg Central shunt flows and pressures in the mature fetal lamb Am J Physiol 241 1981 H60 H66
16. E.D. Michelakis, W. Tymchak, M. Noga Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension Circulation 108 2003 2066 2069
17. R.T. Schermuly, K.P. Kreisselmeier, H.A. Ghofrani Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats Am J Respir Crit Care Med 169 2004 39 45
18. L. Zhao, N.A. Mason, N.W. Morrell Sildenafil inhibits hypoxia-induced pulmonary hypertension Circulation 104 2001 424 428
19. H.A. Ghofrani, R. Wiedemann, F. Rose Sildenafil for treatment of lung fibrosis and pulmonary hypertension a randomised controlled trial Lancet 360 2002 895 900
20. H.A. Ghofrani, R. Voswinckel, F. Reichenberger Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension a randomized prospective study J Am Coll Cardiol 44 2004 1488 1496
21. H.C. Gillies, D. Roblin, G. Jackson Coronary and systemic hemodynamic effects of sildenafil citrate from basic science to clinical studies in patients with cardiovascular disease Int J Cardiol 86 2002 131 141
22. J.P. Richalet, P. Gratadour, P. Robach Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension Am J Respir Crit Care Med 171 2005 275 281
23. L.S. Sanchez, S.M. de la Monte, G. Filippov, R.C. Jones, W.M. Zapol, K.D. Bloch Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development Pediatr Res 43 1998 163 168
24. L. Moreno, B. Losada, A. Cogolludo Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway Pediatr Res 56 2004 563 570
25. J.W. Ziegler, D.D. Ivy, J.J. Fox, J.P. Kinsella, W.R. Clarke, S.H. Abman Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus Am J Physiol 269 1995 H473 H479
26. S.H. Abman, F.J. Accurso Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation Am J Physiol 257 1989 H626 H634
27. T.J. McMahon, L.J. Ignarro, P.J. Kadowitz Influence of zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed J Appl Physiol 74 1993 1704 1711
28. K.G. Thusu, F.C. Morin III, J.A. Russell, R.H. Steinhorn The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide Am J Respir Crit Care Med 152 1995 1605 1610
29. J.W. Ziegler, D.D. Ivy, J.W. Wiggins, J.P. Kinsella, W.R. Clarke, S.H. Abman Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension Am J Respir Crit Care Med 158 1998 1388 1395
30. P. Wang Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases Life Sci 68 2001 1977 1987
31. S.D. Rybalkin, C. Yan, K.E. Bornfeldt, J.A. Beavo Cyclic GMP phosphodiesterases and regulation of smooth muscle function Circ Res 93 2003 280 291
32. S. Jaillard, V. Houfflin-Debarge, Y. Riou Effects of catecholamines on the pulmonary circulation in the ovine fetus Am J Physiol Regul Integr Comp Physiol 281 2001 R607 R614
33. S.H. Abman, F.J. Accurso Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions Am J Physiol 260 1991 H183 H192
34. P. Deruelle, T.R. Grover, L. Storme, S.H. Abman Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus Am J Physiol 288 2005 L727 L733